Herbas VPB

Print
EN | LT
LT - PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTI-RETROVIRAL DRUG AND A PHARMACOKINETIC ENHANCER
EN - PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTI-RETROVIRAL DRUG AND A PHARMACOKINETIC ENHANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61P 31/20 (2018.01)
A61K 31/675 (2006.01)
A61K 31/683 (2006.01)
A61K 47/22 (2013.01)
A61K 31/506 (2013.01)
A61K 31/635 (2006.01)
A61K 31/47 (2013.01)
A61K 45/06 (2006.01)
A61K 31/34 (2006.01)
A61K 31/685 (2013.01)
A61K 31/4525 (2006.01)
A61P 31/12 (2018.01)
A61K 47/22 (2006.01)
A61K 9/209 (2013.01)
A61P 31/18 (2006.01)
A61P 31/18 (2018.01)
A61P 31/20 (2006.01)
A61K 31/675 (2013.01)
A61K 9/20 (2006.01)
A61K 45/06 (2013.01)
A61K 9/24 (2006.01)
A61K 9/2013 (2013.01)
A61K 31/47 (2006.01)
A61K 31/5365 (2013.01)
A61K 31/4525 (2013.01)
A61K 31/506 (2006.01)
A61K 31/635 (2013.01)
A61K 31/5365 (2006.01)
A61K 31/34 (2013.01)
A61K 31/685 (2006.01)
A61P 31/12 (2006.01)
European patent
(11) Number of the document 3413913
(13) Kind of document T
(96) European patent application number 17711359.4
Date of filing the European patent application 2017-02-01
(97) Date of publication of the European application 2018-12-19
(45) Date of publication and mention of the grant of the patent 2021-11-24
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/IN2017/050046
Date 2017-02-01
PCT application publication
(87) Number WO 2017/138022
Date 2017-08-17
Priority applications
(30) Number Date Country code
201621005051 2016-02-12 IN
201621032504 2016-09-23 IN
201621040945 2016-11-30 IN
Inventors
(72)
MALHOTRA, Geena , IN
JOSHI, Kalpana , IN
RAUT, Preeti , IN
GHOSALKAR, Jeevan , IN
Grantee
(73) Cipla Limited , Cipla House Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra 400013, IN
Title
(54) PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTI-RETROVIRAL DRUG AND A PHARMACOKINETIC ENHANCER
  PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTI-RETROVIRAL DRUG AND A PHARMACOKINETIC ENHANCER